The AGM is approaching and shareholders are asked to adopt the resolution to reward the incompetent CEO.
I have posted FACTS to support my assertions of Peter Cook's incompetence and how inadequate GSK's response is when compared to Roche. And by talking down the Relenza market Peter Cook is the impediment to BTA sp achieving its true value.
If you like to discredit my veiws, please do it in an intelligent manner and show which of the facts I posted are wrong.
For other HC readers, please note that I am stating BTA current sp is seriously undervalued as IMHO it does not reflect the Relenza royalties and certainly not the potential of LANI. When the idiot CEO is talking down the Relenza market, it is no rocket science that the market takes a conservative estimate of future Relenza royalties.
BTA Price at posting:
$2.78 Sentiment: None Disclosure: Not Held
